About cstone pharmaceuticals co ltd - CSPHF
Cstone Pharmaceuticals Co. Ltd. is an investment holding company, which engages in the research and development of complex biopharmaceutical products and sale of pharmaceutical products. Its products include immuno-oncology drugs and molecularly targeted drugs. The company was founded on December 2, 2015, and is headquartered in Shanghai, China.
CSPHF At a Glance
CStone Pharmaceuticals Co. Ltd.
North Block Suzhou Industrial Park
Shanghai, Shanghai 200126
| Phone | 86-21-6109-7678 | Revenue | 56.58M | |
| Industry | Pharmaceuticals: Major | Net Income | -12,673,240.52 | |
| Sector | Health Technology | Employees | 135 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
CSPHF Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 6.678 |
| Price to Book Ratio | 7.584 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -52.84 |
| Enterprise Value to Sales | 5.911 |
| Total Debt to Enterprise Value | 0.146 |
CSPHF Efficiency
| Revenue/Employee | 419,120.438 |
| Income Per Employee | -93,875.856 |
| Receivables Turnover | 4.921 |
| Total Asset Turnover | 0.266 |
CSPHF Liquidity
| Current Ratio | 1.598 |
| Quick Ratio | 1.179 |
| Cash Ratio | 0.987 |
CSPHF Profitability
| Gross Margin | 46.767 |
| Operating Margin | -23.417 |
| Pretax Margin | -22.398 |
| Net Margin | -22.398 |
| Return on Assets | -5.96 |
| Return on Equity | -22.182 |
| Return on Total Capital | -12.851 |
| Return on Invested Capital | -13.937 |
CSPHF Capital Structure
| Total Debt to Total Equity | 97.829 |
| Total Debt to Total Capital | 49.451 |
| Total Debt to Total Assets | 25.546 |
| Long-Term Debt to Equity | 72.212 |
| Long-Term Debt to Total Capital | 36.502 |